Stroke-induced opposite and age-dependent changes of vessel-associated markers in co-morbid transgenic mice with Alzheimer-like alterations

Experimental Neurology

Volumn 250, Issue , 2013, Pages 270-281

  Hawkes, Cheryl A ^a   Michalski, Dominik ^b   Anders, Rebecca ^b   Nissel, Sabine ^b   Grosche, Jens ^b   Bechmann, Ingo ^b   Carare, Roxana O ^a   Härtig, Wolfgang ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Alzheimer's disease; Basement membrane; Endothelium; Ischaemic stroke

Indexed keywords

COLLAGEN TYPE 4; LAMININ;

AGE DISTRIBUTION; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENDOTHELIUM; FEMALE; HUMAN; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEOCORTEX; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ALZHEIMER'S DISEASE; BASEMENT MEMBRANE; ENDOTHELIUM; ISCHAEMIC STROKE;

AGING; ALZHEIMER DISEASE; ANIMALS; BASEMENT MEMBRANE; BIOLOGICAL MARKERS; BRAIN; COLLAGEN TYPE IV; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; IMMUNOHISTOCHEMISTRY; LAMININ; MALE; MICE; MICE, TRANSGENIC; STROKE;

EID: 84886254101     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.09.020     Document Type: Article

References (96)

1. Alba C., Vidal L., Díaz F., Villena A., de Vargas I.P. Ultrastructural and quantitative age-related changes in capillaries of the dorsal lateral geniculate nucleus. Brain Res. Bull. 2004, 64:145-153.
2. Albelda S.M., Muller W.A., Buck C.A., Newman P.J. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J. Cell Biol. 1991, 114:1059-1068.
3. Arai K., Jin G., Navaratna D., Lo E.H. Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke. FEBS J. 2009, 276:4644-4652.
4. Bartels A.L., Kortekaas R., Bart J., Willemsen A.T., de Klerk O.L., de Vries J.J., van Oostrom J.C., Leenders K.L. Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol. Aging 2009, 30:1818-1824.
5. Bechmann I., Galea I., Perry V.H. What is the blood-brain barrier (not)?. Trends Immunol. 2007, 28:5-11.
6. Bonita R. Epidemiology of stroke. Lancet 1992, 339:342-344.
7. Bourasset F., Ouellet M., Tremblay C., Julien C., Do T.M., Oddo S., LaFerla F., Calon F. Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease. Neuropharmacology 2009, 56:808-813.
8. Brouns R., De Deyn P.P. The complexity of neurobiological processes in acute ischemic stroke. Clin. Neurol. Neurosurg. 2009, 111:483-495.
9. Burggraf D., Martens H.K., Jäger G., Hamann G.F. Recombinant human tissue plasminogen activator protects the basal lamina in experimental focal cerebral ischemia. Thromb. Haemost. 2003, 89:1072-1080.
10. Burggraf D., Vosko M.R., Schubert M., Stassen J.M., Hamann G.F. Different therapy options protecting microvasculature after experimental cerebral ischaemia and reperfusion. Thromb. Haemost. 2010, 103:891-900.
11. Candelario-Jalil E., Yang Y., Rosenberg G.A. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 2009, 158:983-994.
12. Cipolla M.J. Stroke and the blood-brain interface. Blood-Brain Interfaces: From Ontogeny to Artificial Barriers 2006, 619-647. Wiley-VCH, Weinheim. R. Dermietzel, D.C. Spray, M. Nedergaard (Eds.).
13. del Zoppo G.J. Virchow's triad: the vascular basis of cerebral injury. Rev. Neurol. Dis. 2008, 5(Suppl. 1):12-21.
14. del Zoppo G.J. Relationship of neurovascular elements to neuron injury during ischemia. Cerebrovasc. Dis. 2009, 27(Suppl. 1):65-76.
15. del Zoppo G.J. The neurovascular unit in the setting of stroke. J. Intern. Med. 2010, 267:156-171.
16. del Zoppo G.J. Aging and the neurovascular unit. Ann. N. Y. Acad. Sci. 2012, 1268:127-133.
17. Diener H.C., Lees K.R., Lyden P., Grotta J., Davalos A., Davis S.M., Shuaib A., Ashwood T., Wasiewski W., Alderfer V., Hårdemark H.G., Rodichok L., SAINT I, II Investigators NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke 2008, 39:1751-1758.
18. Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet 2008, 371:1612-1623.
19. Endres M., Engelhardt B., Koistinaho J., Lindvall O., Meairs S., Mohr J.P., Planas A., Rothwell N., Schwaninger M., Schwab M.E., Vivien D., Wieloch T., Dirnagl U. Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc. Dis. 2008, 25:268-278.
20. Erickson A.C., Couchman J.R. Still more complexity in mammalian basement membranes. J. Histochem. Cytochem. 2000, 48:1291-1306.
21. Fukuda S., Fini C.A., Mabuchi T., Koziol J.A., Eggleston L.L., del Zoppo G.J. Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 2004, 35:998-1004.
22. Gama Sosa M.A., Gasperi R.D., Rocher A.B., Wang A.C., Janssen W.G., Flores T., Perez G.M., Schmeidler J., Dickstein D.L., Hof P.R., Elder G.A. Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations. Am. J. Pathol. 2010, 176:353-368.
23. Grammas P., Sanchez A., Tripathy D., Luo E., Martinez J. Vascular signaling abnormalities in Alzheimer disease. Cleve. Clin. J. Med. 2011, 78(Suppl. 1):50-53.
24. Grammas P., Tripathy D., Sanchez A., Yin X., Luo J. Brain microvasculature and hypoxia-related proteins in Alzheimer's disease. Int. J. Clin. Exp. Pathol. 2011, 4:616-627.
25. Hacke W., Kaste M., Bluhmki E., Brozman M., Davalos A., Guidetti D., Larrue V., Lees K.R., Medeghri Z., Machnig T., Schneider D., von Kummer R., Wahlgren N., Toni D., ECASS Investigators Thrombolysis with alteplase 3 to 4.5hours after acute ischemic stroke. N. Engl. J. Med. 2008, 359:1317-1329.
26. Haglund M., Kalaria R., Slade J.Y., Englund E. Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia. Acta Neuropathol. 2006, 111:430-435.
27. Hallmann R., Horn N., Selg M., Wendler O., Pausch F., Sorokin L.M. Expression and function of laminins in the embryonic and mature vasculature. Physiol. Rev. 2005, 85:979-1000.
28. Hamann G.F., Liebetrau M., Martens H., Burggraf D., Kloss C.U., Bültemeier G., Wunderlich N., Jäger G., Pfefferkorn T. Microvascular basal lamina injury after experimental focal cerebral ischemia and reperfusion in the rat. J. Cereb. Blood Flow Metab. 2002, 22:526-533.
29. Han B.H., Zhou M.L., Abousaleh F. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-β peptide, partial restoration via γ-secretase inhibition. J. Neurosci. 2008, 28:13542-13550.
30. Härtig W., Reichenbach A., Voigt C., Boltze J., Bulavina L., Schuhmann M.U., Seeger J., Schusser G.F., Freytag C., Grosche J. Triple fluorescence labelling of neuronal, glial and vascular markers revealing pathological alterations in various animal models. J. Chem. Neuroanat. 2009, 37:128-138.
31. Hecht N., He J., Kremenetskaia I., Nieminen M., Vajkoczy P., Woitzik J. Cerebral hemodynamic reserve and vascular remodeling in C57/BL6 mice are influenced by age. Stroke 2012, 43:3052-3062.
32. Hermann D.M., Zechariah A. Implications of vascular endothelial growth factor for postischemic neurovascular remodeling. J. Cereb. Blood Flow Metab. 2009, 29:1620-1643.
33. Ito U., Hakamata Y., Kawakami E., Oyanagi K. Temporary cerebral ischemia results in swollen astrocytic end-feet that compress microvessels and lead to delayed focal cortical infarction. J. Cereb. Blood Flow Metab. 2011, 31:328-338.
34. Ji K., Tsirka S.E. Inflammation modulates expression of laminin in the central nervous system following ischemic injury. J. Neuroinflammation 2012, 9:159.
35. Jin R., Yang G., Li G. Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol. Dis. 2010, 38:376-385.
36. Kalaria R.N. Cerebral vessels in ageing and Alzheimer's disease. Pharmacol. Ther. 1996, 72:193-214.
37. Kalaria R.N. Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc. Dis. 2002, 13(Suppl. 2):48-52.
38. Kalback W., Esh C., Castaño E.M., Rahman A., Kokjohn T., Luehrs D.C., Sue L., Cisneros R., Gerber F., Richardson C., Bohrmann B., Walker D.G., Beach T.G., Roher A.E. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol. Res. 2004, 26:525-539.
39. Kara F., Dongen E.S., Schliebs R., Buchem M.A., Groot H.J., Alia A. Monitoring blood flow alterations in the Tg2576 mouse model of Alzheimer's disease by in vivo magnetic resonance angiography at 17.6T. Neuroimage 2012, 60:958-966.
40. König I.R., Ziegler A., Bluhmki E., Hacke W., Barth P.M., Sacco R.L., Diener H.C., Weimar C., Virtual International Stroke Trials Archive (VISTA) Investigators Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke 2008, 39:1821-1826.
41. Krupinski J., Stroemer P., Slevin M., Marti E., Kumar P., Rubio F. Three-dimensional structure and survival of newly formed blood vessels after focal cerebral ischemia. Neuroreport 2003, 14:1171-1176.
42. Kwon I., Kim E.H., del Zoppo G.J., Heo J.H. Ultrastructural and temporal changes of the microvascular basement membrane and astrocyte interface following focal cerebral ischemia. J. Neurosci. Res. 2009, 87:668-676.
43. Li L., Liu F., Welser-Alves J.V., McCullough L.D., Milner R. Upregulation of fibronectin and the α5β1 and αvβ3 integrins on blood vessels within the cerebral ischemic penumbra. Exp. Neurol. 2012, 233:283-291.
44. Lin C.Y., Chang C., Cheung W.M., Lin M.H., Chen J.J., Hsu C.Y., Chen J.H., Lin Z.N. Dynamic changes in vascular permeability, cerebral blood volume, vascular density, and size after transient focal cerebral ischemia in rats: evaluation with contrast-enhanced magnetic resonance imaging. J. Cereb. Blood Flow Metab. 2008, 28:1491-1501.
45. Liu F., Yuan R., Benashski S.E., McCullough L.D. Changes in experimental stroke outcome across the life span. J. Cereb. Blood Flow Metab. 2009, 29:792-802.
46. Lo R.Y., Jagust W.J. Vascular burden and Alzheimer disease pathologic progression. Neurology 2012, 79:1349-1355. For the Alzheimer's Disease Neuroimaging Initiative.
47. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
48. Luchsinger J.A., Mayeux R. Cardiovascular risk factors and Alzheimer's disease. Curr. Atheroscler. Rep. 2004, 6:261-266.
49. Massaad C.A., Amin S.K., Hu L. Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer's disease. PLoS One 2010, 5:e10561.
50. Mayeux R., Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2012, 2:a006239.
51. Menzies S.A., Hoff J.T., Betz A.L. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 1992, 31:100-106.
52. Miao J., Xu F., Davis J., Otto-Höller I., Verbeek M.M., Van Nostrand W.E. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am. J. Pathol. 2005, 167:505-515.
53. Morioka T., Kalehua A.N., Streit W.J. Characterization of microglial reaction after middle cerebral artery occlusion in rat brain. J. Comp. Neurol. 1993, 327:123-132.
54. Morris D.C., Yeich T., Khalighi M.M., Soltanian-Zadeh H., Zhang Z.G., Chopp M. Microvascular structure after embolic focal cerebral ischemia in the rat. Brain Res. 2003, 972:31-37.
55. Mrak R.E., Griffin S.T., Graham D.I. Aging-associated changes in human brain. J. Neuropathol. Exp. Neurol. 1997, 56:1269-1275.
56. Nation D.A., Hong S., Jak A.J., Delano-Wood K., Millis P.J., Bondi M.W., Dimsdale J.E. Stress, exercise, and Alzheimer's disease: a neurovascular pathway. Med. Hypotheses 2011, 76:847-854.
57. Neely J.D., Christensen B.M., Nielsen S., Agre P. Heterotetrameric composition of aquaporin-4 water channels. Biochemistry 1999, 38:11156-11163.
58. Nicchia G.P., Nico B., Camassa L.M.A., Mola M.G., Ribatti D., Spray D.C., Bosco A., Svetlo M., Frigeri A. Responsive astrocytic endfeet: the role of AQP4 in BBB development and functioning. Blood-Brain Interfaces: From Ontogeny to Artificial Barriers 2006, 209-236. Wiley-VCH, Weinheim. R. Dermietzel, D.C. Spray, M. Nedergaard (Eds.).
59. Nielsen S., Nagelhus E.A., Amiry-Moghaddam M., Bourque C., Agre P., Ottersen O.P. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J. Neurosci. 1997, 17:171-180.
60. Nikolakakis N., Hamel E. Neurovascular function in Alzheimer's disease patients and experimental models. J. Cereb. Blood Flow Metab. 2011, 31:1354-1370.
61. Oddo S., Caccamo A., Shepherd D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease: intracellular Aβ and synaptic dysfunction. Neuron 2003, 39:409-421.
62. Pan J.R., Li Y., Pei Z., Li X.P., Peng Y., Wang Y.D. Hypoxic tissues are associated with microvessel density following brain ischemia-reperfusion. Neurol. Sci. 2010, 31:765-771.
63. Papadopoulos M.C., Manley G.T., Krishna S., Verkman A.S. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J. 2004, 18:1291-1293.
64. Park L., Anrather J., Zhou P. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid β peptide. J. Neurosci. 2005, 25:1769-1777.
65. Perlmutter L.S. Microvascular pathology and vascular basement membrane components in Alzheimer's disease. Mol. Neurobiol. 1994, 9:33-40.
66. Pimentel-Coelho P.M., Rivest S. The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer's disease. Eur. J. Neurosci. 2012, 35:1917-1937.
67. Popescu B.O., Toescu E.C., Popescu L.M., Bajenaru O., Muresanu D.F., Schultzberg M., Bogdanovic N. Blood-brain barrier alterations in ageing and dementia. J. Neurol. Sci. 2009, 283:99-106.
68. Popp A., Jaenisch N., Witte O.W., Frahm C. Identification of ischemic regions in a rat model of stroke. PLoS One 2009, 4:e4764.
69. Riddle D.R., Sonntag W.E., Lichtenwalner R.J. Microvascular plasticity in aging. Ageing Res. Rev. 2002, 2:149-168.
70. Roher A.E., Esh C., Kokjohn T.A. Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler. Thromb. Vasc. Biol. 2003, 23:2055-2062.
71. Roher A.E., Esh C., Rahman A., Kokjohn T.A., Beach T.G. Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke 2004, 35(Suppl. 1):2623-2627.
72. Roher A.E., Tyas S.L., Maarouf C.L., Daugs I.D., Kokjohn T.A., Emmerling M.R., Garami Z., Belohlavek M., Sabbagh M.N., Sue L.I., Beach T.G. Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia. Alzheimers Dement. 2011, 7:436-444.
73. Rosell A., Lo E.H. Multiphasic roles for matrix metalloproteinases after stroke. Curr. Opin. Pharmacol. 2008, 8:82-89.
74. Sandoval K.E., Witt K.A. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol. Dis. 2008, 32:200-219.
75. Shapira S., Sapir M., Wengier A., Grauer E., Kadar T. Aging has a complex effect on a rat model of ischemic stroke. Brain Res. 2002, 925:148-158.
76. Shin H.K., Jones P.B., Garcia-Alloza M. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain 2007, 130:2310-2319.
77. Steiner E., Enzmann G.U., Lin S., Ghavampour S., Hannocks M.J., Zuber B., Rüegg M.A., Sorokin L., Engelhardt B. Loss of astrocyte polarization upon transient focal brain ischemia as a possible mechanism to counteract early edema formation. Glia 2012, 60:1646-1659.
78. Stoll G., Jander S., Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 1998, 56:149-171.
79. Sun Y., Jin K., Xie L., Childs J., Mao X.O., Logvinova A., Greenberg D.A. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 2003, 111:1843-1851.
80. Taguchi Y., Takashima S., Sasahara E., Inoue H., Ohtani O. Morphological changes in capillaries in the ischemic brain in Wistar rats. Arch. Histol. Cytol. 2004, 67:253-261.
81. Tian J., Shi J., Mann D.M. Cerebral amyloid angiopathy and dementia. Panminerva Med. 2004, 46:253-264.
82. Tian J., Shi J., Smallman R., Iwatsubo T., Mann D.M. Relationships in Alzheimer's disease between the extent of Aβ deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen. Neuropathol. Appl. Neurobiol. 2006, 32:332-440.
83. Timpl R., Brown J.C. Supramolecular assembly of basement membranes. Bioessays 1996, 18:123-132.
84. Trendelenburg G., Dirnagl U. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 2005, 50:307-320.
85. Ueno M. Molecular anatomy of the brain endothelial barrier: an overview of the distributional features. Curr. Med. Chem. 2007, 14:1199-1206.
86. van Assema D.M., Lubberink M., Bauer M., van der Flier W.M., Schuit R.C., Windhorst A.D., Comans E.F., Hoetjes N.J., Tolboom N., Langer O., Müller M., Scheltens P., Lammertsma A.A., van Berckel B.N. Blood-brain barrier P-glycoprotein function in Alzheimer's disease. Brain 2012, 135:181-189.
87. Vogelgesang S., Warzok R.W., Cascorbi I., Kunert-Keil C., Schroeder E., Kroemer H.K., Siegmund W., Walker L.C., Pahnke J. The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease. Curr. Alzheimer Res. 2004, 1:121-125.
88. Whitehead S.N., Cheng G., Hachinski V.C., Cechetto D.F. Progressive increase in infarct size, neuroinflammation, and cognitive deficits in the presence of high levels of amyloid. Stroke 2007, 38:3245-3250.
89. Yamada M. Cerebral amyloid angiopathy: an overview. Neuropathology 2000, 20:8-22.
90. Yamada M., Naiki H. Cerebral amyloid angiopathy. Prog. Mol. Biol. Transl. Sci. 2012, 107:41-78.
91. Yurchenco P.D. Basement membranes: cell scaffoldings and signaling platforms. Cold Spring Harb. Perspect. Biol. 2011, 3:a004911.
92. Yurchenco P.D., Patton B.L. Developmental and pathogenic mechanisms of basement membrane assembly. Curr. Pharm. Des. 2009, 15:1277-1294.
93. Zarow C., Barron E., Chui H.C., Perlmutter L.S. Vascular basement membrane pathology and Alzheimer's disease. Ann. N. Y. Acad. Sci. 1997, 826:147-160.
94. Zhang F., Eckman C., Younkin S., Hsiao K.K., Iadecola C. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. J. Neurosci. 1997, 17:7655-7661.
95. Zhang Q., Gao T., Luo Y., Chen X., Gao G., Gao X., Zhou Y., Dai J. Transient focal cerebral ischemia/reperfusion induces early and chronic axonal changes in rats: its importance for the risk of Alzheimer's disease. PLoS One 2012, 7:e33722.
96. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.